<?xml version="1.0" encoding="UTF-8" standalone="no" ?>
<rss version="2.0">
  <channel>
    <title>Linde, H. van der</title>
    <link>http://repub.eur.nl/res/aut/12908/</link>
    <description>List of Publications</description>
    <language>en</language>
    <image>
      <url>http://repub.eur.nl/static-eur/img/logo.png</url>
      <title>RePub, Erasmus University Rotterdam</title>
      <link>http://repub.eur.nl</link>
    </image>
    <item>
      <title>Mutations in TITF-1 are associated with benign hereditary chorea (Article)</title>
      <link>http://repub.eur.nl/res/pub/9889/</link>
      <pubDate>2002-01-01T00:00:00Z</pubDate>
      <description>Benign hereditary chorea (BHC) (MIM 118700) is an autosomal dominant
      movement disorder. The early onset of symptoms (usually before the age of
      5 years) and the observation that in some BHC families the symptoms tend
      to decrease in adulthood suggests that the disorder results from a
      developmental disturbance of the brain. In contrast to Huntington disease
      (MIM 143100), BHC is non-progressive and patients have normal or slightly
      below normal intelligence. There is considerable inter- and intrafamilial
      variability, including dysarthria, axial dystonia and gait disturbances.
      Previously, we identified a locus for BHC on chromosome 14 and
      subsequently identified additional independent families linked to the same
      locus. Recombination analysis of all chromosome 14-linked families
      resulted initially in a reduction of the critical interval for the BHC
      gene to 8.4 cM between markers D14S49 and D14S278. More detailed analysis
      of the critical region in a small BHC family revealed a de novo deletion
      of 1.2 Mb harboring the TITF-1 gene, a homeodomain-containing
      transcription factor essential for the organogenesis of the lung, thyroid
      and the basal ganglia. Here we report evidence that mutations in TITF-1
      are associated with BHC.</description>
    </item> <item>
      <title>Instability of a (CGG)98 repeat in the Fmr1 promoter (Article)</title>
      <link>http://repub.eur.nl/res/pub/9699/</link>
      <pubDate>2001-01-01T00:00:00Z</pubDate>
      <description>Fragile X syndrome is one of 14 trinucleotide repeat diseases. It arises
      due to expansion of a CGG repeat which is present in the 5'-untranslated
      region of the FMR1 gene, disruption of which leads to mental retardation.
      The mechanisms involved in trinucleotide repeat expansion are poorly
      understood and to date, transgenic mouse models containing transgenic
      expanded CGG repeats have failed to reproduce the instability seen in
      humans. As both cis-acting factors and the genomic context of the CGG
      repeat are thought to play a role in expansion, we have now generated a
      knock-in mouse Fmr1 gene in which the murine (CGG)8 repeat has been
      exchanged with a human (CGG)98 repeat. Unlike other CGG transgenic models,
      this model shows moderate CGG repeat instability upon both in maternal and
      paternal transmission. This model will now enable us to study the timing
      and the mechanism of repeat expansion in mice.</description>
    </item>
  </channel>
</rss>